The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins
- 3 March 1998
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 52 (1-2), 1-16
- https://doi.org/10.1016/s0168-3659(97)00204-6
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Extracellular Conversion of Epidermal Growth Factor (EGF) to des-Arg53-EGF by Carboxypeptidase MJournal of Biological Chemistry, 1995
- Flavonoid Inhibitors of Trypsin and Leucine Aminopeptidase: A Proposed Mathematical Model for IC50 EstimationJournal of Natural Products, 1995
- Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitorsLife Sciences, 1994
- In vitro studies of gastric juice in patients with food-cobalamin malabsorptionDigestive Diseases and Sciences, 1994
- Effect of pH, Dietary Proteins and Trypsin Inhibitors on the Hydrolytic Rate of Human Granulocyte Colony-Stimulating Factor (G-CSF) by Rat Digestive Enzymes.Journal of Pharmacobio-Dynamics, 1991
- Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: Implications in peptide delivery from nonoral routesLife Sciences, 1990
- Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.Hypertension, 1989
- Effect of Synthetic Protease Inhibitor Camostate on Pancreatic Exocrine Function in RatsPancreas, 1987
- Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitorBiochimica et Biophysica Acta (BBA) - General Subjects, 1976
- Human liver aminopeptidase. Role of metal ions in mechanism of actionBiochemistry, 1974